Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

The study found that the enzyme linked to acne is present in the same areas of both acne-affected and normal skin.

Androgenetic alopecia can be treated with minoxidil and finasteride, requiring long-term use and patient cooperation.

Finasteride side effects in young men may be linked to specific gene variations.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

New lipid nanoparticles show promise for delivering hair loss treatments but need improvement for better skin penetration.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Finasteride, when given in high oral doses to pregnant monkeys, caused genital abnormalities in male fetuses, but not in female fetuses or those exposed to intravenous finasteride.

Liposomes could improve how skin care products work but are costly and not very stable.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Hair and nails can help diagnose diseases, with nail issues often linked to skin conditions and hair loss having various causes and treatments.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Hair restoration combines drugs and follicular unit grafting for natural, long-lasting results.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Alcohol in teen years leads to more adult drinking, finasteride doesn't help.

Finasteride exposure affects gene expression and anogenital distance in male rat fetuses.

Dutasteride is more effective and better tolerated than finasteride for hair loss treatment.

Treat hair loss with medicine, continue indefinitely.